4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000140
Chairperson & CEO sold 9,500 shares at an average $500.82 ($4,757,773)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-11 | Sale : show line 2 in the form 10b5-1 | −1,341 | $496.74 | $666,126 | 332,602 | I |
| 2026-09-11 | Sale : show line 3 in the form 10b5-1 | −2,138 | $497.99 | $1,064,700 | 330,464 | I |
| 2026-09-11 | Sale : show line 4 in the form 10b5-1 | −1,021 | $498.97 | $509,446 | 329,443 | I |
| 2026-09-11 | Sale : show line 5 in the form 10b5-1 | −204 | $499.61 | $101,921 | 329,239 | I |
| 2026-09-11 | Sale : show line 6 in the form 10b5-1 | −476 | $500.86 | $238,409 | 328,763 | I |
| 2026-09-11 | Sale : show line 7 in the form 10b5-1 | −1,560 | $502.13 | $783,323 | 327,203 | I |
| 2026-09-11 | Sale : show line 8 in the form 10b5-1 | −850 | $503.10 | $427,634 | 326,353 | I |
| Open-market sales · 9,500 sh · avg $500.82 · $4,757,773 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-11 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option | −9,500 | 451,910 | I |
Loading xslF345X06/primarydocument.xml…